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A B S T R A C T
The paper is a clinical retrospective analysis of free conjunctival autograft in treatment of pterygia. In period from
1998 until 2006, 47 patients with pterygia were operated using free conjunctival autograft. There were 19 female and 38
male, average age 61 years. In the majority of patients (39/47) it was a primary pterygia. Eight patients were on topical
antiglaucoma therapy. Free autograft was taken from superotemporal conjunctiva. Introduction of a single nylon suture
to mark the epithelial side of the graft as well as the use of running 10–0 nylon suture for the graft that stays in up to two
months, were our modifications of the standard technique. The mean follow-up was 18.79.8 months. Free conjunctival
autograft was successfully taken in all patients. Four of them experienced transient graft edema. In glaucoma patients,
delayed healing of the cornea, conjunctival harvest area and the graft was noted. The best corrected visual acuity was im-
proved in all patients, from 1–3 Snellen lines. Recurrence of the pterygium was noted in three patients, two of them al-
ready with recurrent pterygium. Free conjunctival graft is a safe and effective method of pterygium surgery that produces
only few complications and has low recurrence rate. We found useful switch from topical to systemic antiglaucoma ther-
apy as well as adjunctive use of autologous serum drops in promoting and accelerating healing in glaucoma patients.
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Introduction
Pterygia are triangular fleshy fibrovascular over-
growths of the conjunctiva onto the cornea1 (Figure 1).
Etiology most likely lies in the influence of ultraviolet ra-
diation, dust, heat, wind and dry atmosphere2. Limbal
basal epithelium was found to be the origin of advancing
cells at the head of pterygium3. True mechanism of its
growth onto the cornea is unknown4. Pterygia should be
removed only if there is recent progression threatening
vision. Avulsion1, simple excision1, bare-sclera techni-
que5, rotation and sliding conjunctival flap6, limbal and
free conjunctival autograft7, autologous cultivated con-
junctival transplantation8, amniotic membrane trans-
plantation9 and lamellar corneal grafts1 have all been
used. Adjunctive therapy consists of antimetabolites such
as triethylene thiophosphoramide (thiotepa)4, mitomy-
cine C10 and daunorubicin11, beta-irradiation12, laser and
thermal cautery13. However, the recurrence rate was up
to 40% in various studies7–13,14,15, nearly all seen by one
year of surgery16.
The aim of this paper was retrospective analysis of
free conjunctival autograft (not involving limbal area) in
treatment of primary and recurrent pterygia.
Materials and Methods
In period from December 1998 until January 2006, 47
patients with pterygia were operated by the same author
(BKE) using free conjunctival autograft. There were 19
female and 38 male, average age 6213.8 years, median
63 years (38–83 years). There were 39 primary and eight
recurrent pterygia. Primary surgery was done elsewhere
using sliding conjunctival flap involving approximation
of superior and inferior edges of conjunctiva with su-
tures, without passing the sclera. No motility distur-
bances were present on neither of patients. Eight pa-
tients were on topical antiglaucoma therapy, three as
monotherapy, two on dual and the rest on triple therapy.
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The duration of the therapy was from 5–14 years. Five of
these patients were on therapy for 10–14 years (one pa-
tient on monotherapy, one on dual and three patients on
triple therapy).
Excision of pterygia was performed in local anesthesia
(2% lidocaine with epinephrine (Xylocaine) 1.5 mL para-
bulbar and 0.5 mL subconjunctival under the body of
pterygium). Ophthalmic surgeon sat at 12 o’clock posi-
tion. Two horizontal and one vertical incision were made
to dissect the body of pterygium from the sclera. It was
then reflected centrally. Residual epibulbar scar tissue
was removed, light cautery applied to the sclera and at-
tachments of the pterygium to the limbus severed. The
body of pterygium was grasped to avulse the head of
pterygium from the cornea. If it was not possible, la-
mellar keratectomy was performed. The depth of the cut
in the cornea was usually beneath Bowman’s layer.
Patient was then asked to look down and nasally to
expose the superotemporal bulbar conjunctiva. Xylocaine
(0.5 mL) was injected subconjunctivally very close to the
surface to lift the epithelium. Paper template was used to
record the size and the shape of the graft. Conjunctiva
was accordingly outlined with the cautery. No limbal
area was involved. One 10–0 nylon suture was placed in
the middle of the graft-to-be to mark the epithelial sur-
face of the conjunctiva (Figure 2). The knot was tide 2
mm in front of the conjunctival surface. The bulbar con-
junctiva was dissected with blunt-tipped Westcott scis-
sors. In 10 patients radiofrequency (Ellman) unit was
used for conjunctiva harvest because it was briefly avail-
able to us.
The graft was transported onto the bare sclera hold-
ing it by the preplaced knot in a form of a closed um-
brella. In the first 11 patients 9–0 polyglactin suture
(Vicryl) was used to secure the graft to the edges of con-
junctiva and episclera. In five of them these were inter-
rupted sutures and in the rest a running suture. After
that we started using running 10–0 nylon suture as a
routine.
Topical 1% tropicamide (Mydryacil) and tobramycine
(Tobrex) drops were applied and the eye patched. The
same cycloplegic agent was instilled twice a day until the
inflammation subsided. Corticosteroid drops were intro-
duced usually 3–6 days after the surgery when the har-
vesting area and the corneal surface were healed.
Topical antiglaucoma medication was stopped for the
duration of healing. Acetazolamide (Diamox) tbl a 250
mg and potassium chloride tablets (KCl) were given to
control the intraocular pressure. Since 2003, in all pa-
tients with topical antiglaucoma medication and those
with recurrent pterygia, autologous serum drops were
applied 10 times a day until the healing was complete,
the graft was taken and the suture removed. The mean
follow-up was 18.79.8 months, median 18 months (ran-
ge 6–36 months).
Results
Free conjunctival autograft was successfully taken in
all patients. Four of them experienced transient graft
edema that occurred 3–7 days postoperatively and lasted
from 10–14 days. It was treated early with pressure
patching and, after conjunctiva and cornea healed, with
topical corticosteroid drops. In one patient with severe
graft edema, small dellen developed at the limbal area
adjacent to the graft. Topical corticosteroid therapy was
stopped, autologous serum introduced and the eye pat-
ched. It resolved in 10 days.
In five out of 11 patients with polyglactin 9–0 suture
(two with interrupted and three with running suture)
granuloma was noted at the conjunctival edge 11–18
days after the surgery. Suture was taken out. In one pa-
tient the graft came partially off after the suture removal
due to granuloma formation. The suture was taken out
13 days postoperatively and the patient came back two
days later with the complaint of epiphora and foreign
body sensation after rubbing the eye. Two-thirds of the
graft came off the host bed and the 10–0 nylon suture
had to be placed. The graft healed well.
Cornea healed in all but eight glaucoma patients in 48
to 72 hours. In these eight patients delayed healing of the
cornea, conjunctival harvest area and the graft was no-
ted. Topical therapy was removed and the patients were
B. Kuzmanovi} Elabjer et al.: Free Conjunctival Autograft in Pterygia, Coll. Antropol. 32 (2008) 1: 303–306
304
Fig. 1. Pterygium – a fleshy fibrovascular overgrowth of the
conjunctiva on the cornea
Fig. 2. One 10–0 nylon suture placed in the middle of the
graft-to-be to mark the epithelial surface
kept on oral acetazolamide tablets until the healing was
completed. In two patients on single topical agents it
took 4–6 days for harvesting area and cornea to heal.
However, in one patient who was on monotherapy for
longer than 10 years as well as in all patients on dual and
triple therapy, it took 7–10 days for the healing to occur.
The best corrected visual acuity was improved in all
patients, from 1–3 Snellen lines.
Recurrence of the pterygium was noted in three pa-
tients, two of them already with recurrent pterygia. In
two patients, it was noticed 2 months postoperatively
and in one patient 3 months postoperatively. In patient
with recurrence after 3 months, pterygium was operated
using conjunctival autograft not involving limbal area,
combined with intraoperative use of mitomycine C. How-
ever, it recurred again, but this time it stopped at 1.5 mm
from limbus on cornea. No further attempts were made
to operate it. It stayed the same for 3 years. In the re-
maining two patients with recurrence at two months af-
ter surgery, pterygium was reoperated using free conjun-
ctival autograft. The follow-up is five and three months
respectively, without recurrence.
Discussion
Surgery is the treatment of choice for pterygium.
There is no ideal procedure that would guarantee no re-
currence. Free conjunctival autograft has been reported
as an effective method with low recurrence rate17,18. Ac-
cording to available literature, the recurrence rate for
limbal versus free conjunctival autograft does not differ
significantly7. We started using free conjunctival auto-
graft in 1998. Since few complications were experienced
and recurrence rate was low, we have stuck to this tech-
nique until today. Only superotemporal bulbar conjunc-
tiva was used. We found lidocaine 2% with epinephrine
given in dosage of 0.5 mL subconjunctival under the har-
vesting area useful in terms of additional anesthesia,
hemostasis and elevation of conjunctiva from Tenon’s
capsule. Subsequently, we’ve got thin graft and smooth
harvest area that heal fast and provide satisfactory func-
tional and cosmetic result at the harvest and host bed
(Figure 3).
There are different ways to mark the epithelial sur-
face of the conjunctival autograft1. In the first 5 patients
the surgeon found it very complicated to make sure that
the epithelial side was not apposed to the sclera. Gentian
violet was not available, so fluorescein was used as well
as cautery marks. Then the surgeon started using the
10–0 single suture at the centre of the graft-to-be to
mark the epithelial surface. The knot was tied two milli-
meters above the surface to allow elevation and transpor-
tation of the graft in a way of a closed umbrella. To the
best of our knowledge and the search of the available lit-
erature this is the first time that this technique of mark-
ing the graft is reported.
Radiofrequency unit (Ellman) has been available to
us only briefly. We found it to be easy and safe method for
conjunctival autograft harvesting as reported in litera-
ture19.
Polyglactin 9–0 suture was rather difficult to put on
thin graft and host conjunctiva edge, interrupted or run-
ning. First, we have used interrupted sutures. Every
time the needle was introduced to the graft edge and
tried to pass it through, the edge rolled in. Patients com-
plained of foreign body sensation, probably due to the
knot irritation. Therefore, we have tried with running
9–0 polyglactin suture. It did not make life any easier to
the surgeon, but patients were complaining less. How-
ever, granuloma was noted at the conjunctival edges in
five patients. Although reperfusion of conjunctival auto-
graft occurs as early as one week postoperatively20, in
one patient the graft came partially off after the suture
removal due to granuloma formation 13 days postopera-
tively. For all these reasons, 10–0 nylon running suture
was introduced. It made the surgeon very happy to start
with, patients complained less of foreign body sensation
and it could be left in for 1.5–2 months to make sure that
edges of the host area and the graft healed together. Al-
though there were complication reported with the use of
nylon in suturing the graft such as superficial corneal
vessels development21 we had none.
Topical antiglaucoma therapy, especially dual and tri-
ple therapy was found to postpone the healing of the har-
vest area and the graft in the analyzed group of patients.
Reviewing the literature, we found no reports of such
complication. We also noted that healing was slower in
patients who were under the glaucoma therapy for more
than 10 years. Therefore, in our patients following ptery-
gium surgery, all topical agents were routinely removed
and replaced with oral acetazolamide tablets, until heal-
ing took place. Additionally, since 2003, autologous se-
rum has been introduced as an adjunctive postoperative
therapy. In our experience it has shown great potential in
improving the healing of complicated cases.
Some degree of corneal scarring was inevitable in our
patients because diamond burr was not available and the
tags were scraped with the crescent blade. However, sat-
isfactory improvement of the best corrected visual acuity
and cosmesis was noted in all our patients.
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Fig. 3. Postoperative finding seven months after the procedure in
79-year-old male patient
Conclusion
Free conjunctival graft is a safe and effective method
of pterygium surgery that produces only few complica-
tions and has low recurrence rate. Introduction of single
nylon suture to mark the epithelial side of the graft that
also helps its transport to the host area in a way of a
closed umbrella, as well as the use of running 10–0 nylon
suture for the graft, that stays in up to two months, are
our modifications of the standard technique. Also, we
found that the replacement of the topical with oral anti-
glaucoma medication for the time of healing as well as
adjunctive use of autologous serum drops, promote and
accelerate epithelization in glaucoma patients.
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RETROSPEKTIVNA KLINI^KA STUDIJA SLOBODNOG SPOJNI^NOG PRESATKA
U LIJE^ENJU PTERIGIJA
S A @ E T A K
Prikazani su rezultati retrospektivne klini~ke studije slobodnog spojni~nog presatka u lije~enju pterigija. U periodu
od 1998. do 2006. godine, 47 pacijenata s pterigijem je operirano uporabom slobodnog spojni~nog presatka. Bilo je 19
`ena i 38 mu{karaca, prosje~ne dobi od 61 godinu. Osmero ih je bilo na topikalnoj antiglaukomskoj terapiji. Slobodni
spojni~ni presadak je uzet sa superotemporalnog dijela spojnice bulbusa. Na{a modifikacija standardne tehnike se sa-
stojala u uporabi pojedina~nog najlonskog {ava za ozna~avanje epitelne strane presatka te 10–0 najlonski produ`ni {av
za presadak koji ostaje do dva mjeseca. Prosje~no vrijeme pra}enja je bilo 18,79,8 mjeseci. Slobodni spojni~ni presadak
se uredno primio u svih pacijenata. ^etvero pacijenata je imalo prolazni edem presatka. U glaukomskih pacijenata je
bilo produljeno vrijeme cijeljenja ro`nice i spojnice. Svi pacijenti su imali pobolj{anje vidne o{trine postoperativno za
1–3 reda na Snellenovim optotipima. Ponovna pojava pterigija je zabilje`ena u troje pacijenta s ve} rekurentnim pteri-
gijem. Slobodni spojni~ni presadak je sigurna i uspje{na metoda u lije~enju pterigija koja je u na{oj populaciji bila pra}e-
na s vrlo malo komplikacija i malim postotkom ponovnih pterigija. Kod glaukomskih pacijenta su prelazak s topikalne
na sistemnu antiglaukomsku terapiju i uporaba autolognog seruma postoperativno pridonijeli cijeljenju spojnice.
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